Real Estate & Construction » Real Estate | Microlin Bio Inc.

Microlin Bio Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
Cash & Short Term Investments
7.50
1.90
Total Accounts Receivable
-
1.20
Other Current Assets
93.80
-
Total Current Assets
101.20
3.10
Total Assets
101.20
3.10
ST Debt & Current Portion LT Debt
31.30
32.00
Other Current Liabilities
16.40
11.10
Total Current Liabilities
47.60
43.10
Total Liabilities
47.60
43.10
Common Equity (Total)
53.60
40.00
Total Shareholders' Equity
53.60
40.00
Total Equity
53.60
40.00
Liabilities & Shareholders' Equity
101.20
3.10

About Microlin Bio

View Profile
Address
358 Frankfort Street
New York New York 94104
United States
Employees -
Website http://www.microlinbio.com
Updated 09/14/2018
Microlin Bio, Inc. is a biopharmaceutical company, which engages in the development of microribonucleic acid therapeutics. It offers programs for cancer therapeutics and delivery platform technology. The company was founded by Joseph Hernandez on January 27, 2013 and is headquartered in New York, NY.